LivaNova PLC (NASDAQ:LIVN) shares rose 3% on Friday . The stock traded as high as $62.59 and last traded at $62.56, with a volume of 300,797 shares changing hands. The stock had previously closed at $60.71.

Separately, Piper Jaffray Cos. reissued an “overweight” rating and issued a $70.00 price target (up from $59.00) on shares of LivaNova PLC in a report on Friday, August 5th. Five analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $69.00.

The company has a 50-day moving average of $53.10 and a 200 day moving average of $53.07. The firm’s market cap is $3.07 billion.

In related news, insider Jacques Gutedel sold 4,000 shares of the business’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $60.52, for a total transaction of $242,080.00. Following the transaction, the insider now directly owns 10,948 shares in the company, valued at $662,572.96. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Hugh M. Morrison sold 3,600 shares of the business’s stock in a transaction dated Thursday, May 19th. The stock was sold at an average price of $48.00, for a total transaction of $172,800.00. Following the transaction, the director now owns 5,215 shares in the company, valued at $250,320. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors have recently added to or reduced their stakes in LIVN. Wells Fargo & Company MN purchased a new position in LivaNova PLC during the fourth quarter valued at $30,246,000. Schroder Investment Management Group purchased a new position in LivaNova PLC during the fourth quarter valued at $22,818,000. American International Group Inc. purchased a new position in LivaNova PLC during the fourth quarter valued at $5,731,000. KBC Group NV purchased a new position in LivaNova PLC during the fourth quarter valued at $4,610,000. Finally, Nicholas Co. Inc. WI purchased a new position in LivaNova PLC during the fourth quarter valued at $4,034,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.